These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The interpretation of the thyroid stimulating hormone (TSH) assay].
    Author: Wiersinga WM.
    Journal: Ned Tijdschr Geneeskd; 2003 Jun 14; 147(24):1156-8. PubMed ID: 12845833.
    Abstract:
    Current immunometric TSH assays guarantee a functional sensitivity of at least 0.10 mU/l. The 95% confidence interval of TSH reference values is 0.45-4.12 mU/l; it becomes slightly broader above the age of 60 years (0.4-5.9 mU/l for 70-79 years). Interference by heterophilic antibodies in the TSH assay may give rise to spuriously elevated TSH values. The TSH assay is a very accurate diagnostic test for screening thyroid function. A normal TSH indicates euthyroidism with an accuracy of > 99%; only the rare patient with central hypothyroidism may be overlooked, but the history usually provides sufficient clues to suspect hypothalamic or pituitary disease. In case of an abnormal TSH value, a FT4 assay should be done. Each of the six possible outcomes (decreased or increased TSH combined with a decreased, normal or increased FT4 value) points to a specific diagnosis with an accuracy of over 90%. In the follow-up of treatment of thyroid function disorders, TSH target values are slightly different from the normal reference values. In primary hypothyroidism one aims at TSH values between 0.25 and 2.0 mU/l, but should avoid TSH values < or = 0.10 mU/l. In differentiated thyroid cancer, following complete thyroid ablation the target value is < or = 0.10 mU/l. A decreased TSH value in the course of treatment for Graves' hyperthyroidism does not necessarily indicate thyrotoxicosis, but may reflect persisting levels of TSH receptor stimulating antibodies.
    [Abstract] [Full Text] [Related] [New Search]